Answers are grounded in this paper and cite their sources.
Investigates sappanchalcone's effect on platelet aggregation, indicating potential as an antithrombotic agent.
In order to control excessive activation of platelets, which is a key pathological mechanism of thrombosis, the discovery of highly efficacious natural compounds with favorable cytotoxicity profiles has recently received attention.This study focused on sappanchalcone, a flavonoid derived from Caesalpinia sappan L. In particular, considering that this substance shares structural and functional similarities with existing chalcone derivatives with proven antiplatelet efficacy, we sought to verify its inhibitory effect on platelet activity and thrombus formation process.Using washed human platelets as a model, we analyzed the effects of U46619 stimulation on the aggregation response, intracellular signal transduction, and granule secretion mechanism.The results showed that sappanchalcone inhibited U46619-induced human platelet aggregation in a concentration-dependent manner without negatively affecting cell viability.The specific mechanism of action significantly reduced intracellular calcium mobilization through blocking the phosphoinositide 3-kinase/protein kinase B (PI3K/ Akt) signaling pathway.Furthermore, sappanchalcone significantly attenuated the phosphorylation process of Erk, JNK, and p38, which are members of the mitogen-activated protein kinases (MAPK) family, and thereby effectively inhibited the release of ATP and serotonin in dense granules.As a result, sappanchalcone inhibited fibrinogen binding between platelets in a concentrationdependent manner and ultimately reduced thrombin-induced clot retraction for thrombus formation.These results demonstrated that sappanchalcone extensively inhibits platelet activation, aggregation, and the cascade of thrombus stabilization processes through the downregulation of MAPK and PI3K/Akt signaling systems in vitro using human platelets.In conclusion, this study suggests that sappanchalcone has potential as a promising natural antithrombotic candidate with antiplatelet efficacy.
No takes yet. Share an insight, caveat, or question.
Dong-Ha Lee (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: